{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"105","value":"285"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Flow cytometric analysis of CD4 t-cell t-cell reconstitution was performed at day +100 post-transplant.","dispersionType":"Standard Error","groups":[{"description":"Participants will receive one of two standard myeloablative conditioning regimens for their stem cell transplant, and will receive an aGvHD prophylaxis regimen including cyclosporine, methotrexate, and abatacept.\n\nAbatacept: Participants will receive one of two standard myeloablative conditioning regimens for their stem cell transplant, and will receive an aGvHD prophylaxis regimen including cyclosporine, methotrexate, and abatacept.","id":"OG000","title":"Abatacept"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Day +100 post-transplant","title":"Hematologic and Immunologic Reconstitution","type":"SECONDARY","unitOfMeasure":"cell per microlitre"}